JP2023527926A5 - - Google Patents
Info
- Publication number
- JP2023527926A5 JP2023527926A5 JP2022574537A JP2022574537A JP2023527926A5 JP 2023527926 A5 JP2023527926 A5 JP 2023527926A5 JP 2022574537 A JP2022574537 A JP 2022574537A JP 2022574537 A JP2022574537 A JP 2022574537A JP 2023527926 A5 JP2023527926 A5 JP 2023527926A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody molecule
- therapeutic antibody
- pharmaceutical preparation
- diseases
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20178287.7A EP3919077A1 (en) | 2020-06-04 | 2020-06-04 | Model for prediction of tolerability issues in connection with intravenous administration of therapeutic antibodies |
| EP20178287.7 | 2020-06-04 | ||
| EP21163703 | 2021-03-19 | ||
| EP21163703.8 | 2021-03-19 | ||
| PCT/EP2021/065014 WO2021245238A1 (en) | 2020-06-04 | 2021-06-04 | Improving antibody tolerability associated with intravenous administration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023527926A JP2023527926A (ja) | 2023-06-30 |
| JP2023527926A5 true JP2023527926A5 (https=) | 2024-05-23 |
Family
ID=76217874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022574537A Pending JP2023527926A (ja) | 2020-06-04 | 2021-06-04 | 静脈内投与と関連する抗体耐容性の改善 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20230322933A1 (https=) |
| EP (2) | EP4161574A1 (https=) |
| JP (1) | JP2023527926A (https=) |
| KR (1) | KR20230038180A (https=) |
| CN (1) | CN116322767A (https=) |
| AU (1) | AU2021286202A1 (https=) |
| BR (1) | BR112022024745A2 (https=) |
| CA (1) | CA3185020A1 (https=) |
| IL (1) | IL298757A (https=) |
| MX (1) | MX2022015229A (https=) |
| TW (3) | TW202210103A (https=) |
| WO (3) | WO2021245238A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202342057A (zh) * | 2022-02-07 | 2023-11-01 | 美商健生生物科技公司 | 用於減少用ｅｇｆｒ／ｍｅｔ雙特異性抗體治療之患者的輸注相關反應之方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2196002T3 (es) | 1991-07-25 | 2003-12-16 | Idec Pharma Corp | Anticuerpos recombinantes para terapia humana. |
| US8187593B2 (en) * | 2002-08-14 | 2012-05-29 | Macrogenics, Inc. | FcγRIIB specific antibodies and methods of use thereof |
| EP2490715A4 (en) * | 2009-10-21 | 2013-06-26 | Immunogen Inc | NEW DOSAGE ADMINISTRATION REGIMEN AND METHOD OF TREATMENT |
| GB201013989D0 (en) * | 2010-08-20 | 2010-10-06 | Univ Southampton | Biological materials and methods of using the same |
| GB2526139A (en) | 2014-05-15 | 2015-11-18 | Biolnvent Internat Ab | Medicaments, uses and methods |
| AU2016378573A1 (en) * | 2015-12-22 | 2018-07-19 | Regeneron Pharmaceuticals, Inc. | Bispecific anti-CD20/anti-CD3 antibodies to treat acute lymphoblastic leukemia |
| WO2019081983A1 (en) * | 2017-10-25 | 2019-05-02 | Novartis Ag | CD32B TARGETING ANTIBODIES AND METHODS OF USE |
| EP3737698A2 (en) | 2018-01-10 | 2020-11-18 | BioInvent International AB | Novel combination and use of antibodies |
| MX2021001058A (es) | 2018-08-16 | 2021-04-12 | Genmab As | Conjugados de anticuerpo anti-factor tisular-farmaco y su uso en el tratamiento de un cancer. |
| CA3110513A1 (en) | 2018-08-31 | 2020-03-05 | Regeneron Pharmaceuticals, Inc. | Dosing strategy that mitigates cytokine release syndrome for cd3/c20 bispecific antibodies |
-
2021
- 2021-06-04 WO PCT/EP2021/065014 patent/WO2021245238A1/en not_active Ceased
- 2021-06-04 EP EP21729338.0A patent/EP4161574A1/en active Pending
- 2021-06-04 TW TW110120463A patent/TW202210103A/zh unknown
- 2021-06-04 US US18/008,134 patent/US20230322933A1/en active Pending
- 2021-06-04 WO PCT/EP2021/065013 patent/WO2021245237A1/en not_active Ceased
- 2021-06-04 EP EP21729337.2A patent/EP4161573A1/en active Pending
- 2021-06-04 TW TW110120464A patent/TW202210104A/zh unknown
- 2021-06-04 WO PCT/EP2021/065005 patent/WO2021245233A1/en not_active Ceased
- 2021-06-04 CA CA3185020A patent/CA3185020A1/en active Pending
- 2021-06-04 KR KR1020237000393A patent/KR20230038180A/ko active Pending
- 2021-06-04 TW TW110120461A patent/TW202210102A/zh unknown
- 2021-06-04 MX MX2022015229A patent/MX2022015229A/es unknown
- 2021-06-04 AU AU2021286202A patent/AU2021286202A1/en active Pending
- 2021-06-04 US US18/008,141 patent/US20240301070A1/en active Pending
- 2021-06-04 JP JP2022574537A patent/JP2023527926A/ja active Pending
- 2021-06-04 BR BR112022024745A patent/BR112022024745A2/pt unknown
- 2021-06-04 CN CN202180058034.4A patent/CN116322767A/zh active Pending
- 2021-06-04 IL IL298757A patent/IL298757A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024174927A5 (https=) | ||
| JP2025020134A5 (https=) | ||
| JP2023166388A5 (https=) | ||
| JP2016074740A5 (https=) | ||
| CN1111414C (zh) | 镁盐或镁配合物的制药用途 | |
| CA2901413A1 (en) | Use of levocetirizine and montelukast in the treatment of vasculitis | |
| JP2005506345A5 (https=) | ||
| WO2021142320A1 (en) | Methods of using andrographolide, oridonin and isoliquiritigenin and derivatives thereof | |
| JP2025148449A5 (https=) | ||
| IL307751B1 (en) | Treatment of lupus nephritis with anti-type i inf receptor antibody anifrolumab | |
| JP2023527926A5 (https=) | ||
| JP2002530353A5 (https=) | ||
| KR20120138229A (ko) | 정맥내 투여용 이부프로펜을 이용한 중증 환자의 치료 | |
| JP2024542777A5 (https=) | ||
| CN115463118A (zh) | 和厚朴酚在制备治疗或预防毛细血管瘤的药物中的用途 | |
| Waymack et al. | A prospective trial of prophylactic intravenous immune globulin for the prevention of infections in severely burned patients | |
| KR100302994B1 (ko) | 약독화된비면역원성폭스바이러스또는파라폭스바이러스로부터멀티포텐트파라폭스면역유발인자의약제로서이용하는새로운적용 | |
| JP2005529152A5 (https=) | ||
| JP4580479B2 (ja) | 抗ｈｉｖ感染症剤 | |
| US20070122384A1 (en) | Method for treating inflammatory bowel disease | |
| JP2023550043A5 (https=) | ||
| CN108014337B (zh) | 一种用于治疗眼自身免疫性葡萄膜炎的药物组合物 | |
| WO2000038682A1 (en) | Anti-hiv infection agents and method for treating hiv infection | |
| WO2007041964A1 (fr) | Utilisation de recepteur long du facteur de necrose tumorale alpha soluble recombinant humain de demi-vie dans la preparation de medicament pouvant prevenir l'insuffisance hepatique | |
| CN117243946A (zh) | 瑞香素及包含其的组合物在制备治疗心肌炎药物中的应用 |